| The impact of beta-blockade on mortality rates in patients with congestive heart failure. | |
| | |
MedLine Citation:
|
PMID: 10908094 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The beneficial effects of beta-adrenergic blockade on mortality rates in patients after a myocardial infarction have been clear for decades. The efficacy data are now just as apparent for patients with heart failure. Although there are many subgroups of patients in whom the mortality effects of beta-blockers are not proven, knowledge about these specific populations continues to increase. Nevertheless, more information is needed so that we can properly tailor our therapy for individual patients. |
| | |
Authors:
|
S Goldstein; S S Gottlieb |
Related Documents
:
|
9814234 - Development of an ed teaching program aimed at reducing prehospital delays for patients... 18793034 - Long-term cost-effectiveness analysis of nebivolol compared with standard care in elder... 3304964 - Haemodynamic aspects of nitrate tolerance. 8910074 - Non-invasive prognostic factors in chronic heart failure. one-year survival of 300 pati... 448914 - Thyroid function screening in psychiatric patients. 9405014 - The effect of mobilisation of patients during treatment of thromboembolic disorders wit... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of cardiac failure Volume: 6 ISSN: 1071-9164 ISO Abbreviation: J. Card. Fail. Publication Date: 2000 Jun |
Date Detail:
|
Created Date: 2000-11-21 Completed Date: 2000-11-21 Revised Date: 2013-05-28 |
Medline Journal Info:
|
Nlm Unique ID: 9442138 Medline TA: J Card Fail Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 15-24 Citation Subset: IM |
Affiliation:
|
Henry Ford Hospital, Cardiovascular Medicine, Detroit, Michigan 48202, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use* Bisoprolol / therapeutic use* Carbazoles / therapeutic use* Heart Failure / drug therapy*, mortality Humans Meta-Analysis as Topic Metoprolol / therapeutic use* Patient Selection Propanolamines / therapeutic use* Randomized Controlled Trials as Topic Risk Factors Survival Analysis Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Carbazoles; 0/Propanolamines; 0K47UL67F2/carvedilol; 37350-58-6/Metoprolol; 66722-44-9/Bisoprolol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mechanistic and clinical rationales for using beta-blockers in heart failure.
Next Document: The role of beta-blockers in preventing sudden death in heart failure.